Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

The Big Squeeze: How to Handle Higher Costs, Shrinking Reimbursements, and Regulations That Endanger Your Practice

April 13th 2012

Shrinking reimbursements and higher healthcare costs are making it difficult for community oncologists to stay in practice.

Optical Biomarkers Distinguish Risk Levels in Barrett's Esophagus

April 12th 2012

Optical biomarkers derived from nondysplastic metaplastic cells can detect the presence of high-grade dysplasia and adenocarcinoma from Barrett's esophagus.

New Indicator May Help Identify Patients With Increased Risk From Throat Cancer

March 19th 2012

Patients with oropharyngeal squamous cell carcinoma who had matted lymph nodes -- nodes that are connected together -- are more likely to metastasize than those without matted lymph nodes.

Tivantinib Extends Time to Progression in HCC Patients

March 19th 2012

Treatment with tivantinib produced a 56% improvement in time-to-progression in patients with hepatocellular carcinoma.

Surgical Breast Biopsy Not Overused, Study Suggests

March 19th 2012

Contrary to earlier findings, surgical breast biopsies may not be as overused as previously thought, according to a recent study published in the Journal of the American College of Radiology.

Where Are the Drugs?

February 24th 2012

In 2011, the FDA reported 232 cancer therapies to be in limited supply. As a result, many patients have had therapies delayed or discontinued, and in some cases, patients have been left without access to appropriate alternatives.

FDA Takes Aggressive Steps to Reduce Drug Shortages

February 21st 2012

The FDA announced plans to strengthen the supply of 2 scarce cancer drugs: methotrexate and Doxil.

John Theurer Cancer Center at Hackensack University Medical Center: Providing Extraordinary Care to the Community

February 14th 2012

Year after year, the John Theurer Cancer Center (JTCC) harnesses the newest technologies and retains world-class oncologists, nurses, and scientists to fulfill its mission of delivering extraordinary care to patients in the community.

Electronic Ordering System Improves Chemotherapy Care

February 7th 2012

Human errors can cause higher-than-expected medication error rates and delays in getting the proper chemotherapy doses to the patients who need them.

January 2012: Trials in Progress

February 1st 2012

The Trials in Progress section supplies summaries of ongoing research in a broad range of cancer types.

Molecular Target Testing: Advances Prompt Questions About Costs and Strategies

January 30th 2012

It is increasingly recognized that the realm of molecular diagnostic testing in oncology is undergoing as much change, if not more, as the world of cancer therapeutics.

Radium-223 Properties Conducive to mCRPC Care

December 30th 2011

Radium-223, an alpha-emitting radiopharmaceutical, has been shown to improve overall survival (OS) in men with metastatic castrationresistant prostate cancer (mCRPC) in an interim analysis of the ALSYMPCA trial.

Statins linked to lower risk of prostate cancer mortality in middle-aged men

December 30th 2011

Middle-aged men taking a class of drugs called statins to reduce cholesterol levels were shown to have reduced the risk of mortality due to prostate cancer by approximately 50%, according to a new study...

Chemo Controversy: An Inside Look at the 'Hot Chemotherapy Bath'

December 30th 2011

There is an ongoing debate in the oncology community about a treatment technique that involves cutting all visible cancer out of the abdomen and then flooding the cavity with heated chemotherapy drugs. The procedure -- known as cytoreductive surgery (CRS) -- followed by hyperthermic intraperitoneal chemotherapy (HIPEC), or a

Avastin Increases PFS in Patients With Ovarian Cancer

December 29th 2011

Bevacizumab (Avastin) improved progression-free survival (PFS) in patients with ovarian cancer but was not shown to affect overall survival (OS), according to a new study...

New FDA-Approved Oncology Drugs and Indications, 2011

December 29th 2011

This chart lists the new FDA-approved oncology drugs of 2011 and indications.

The Year's New Drugs: Integrating Advances of 2011 Into Treatment Plans

December 29th 2011

The FDA approved more new oncology drugs in 2011 than it has in a single year in more than a decade, thanks in part to priority review and streamlined evaluation procedures. While this is good news for patients, oncology and hematology specialists must tackle the challenges posed by integrating new therapies into treatment plans. Leading specialists give their perspectives on key issues.

Overcoming Resistance to Endocrine Therapies

December 29th 2011

Patients with hormone receptor-positive metastatic breast cancer (MBC) frequently respond to multiple lines of endocrine therapy but, unfortunately, resistance eventually develops.

Danish Study Finds No Link Between Cell Phone Use and Cancer

December 29th 2011

Danish investigators are reporting that long-term cell phone use does not appear to boost the risk of central nervous system (CNS) tumors.

Exelixis Finds Great Promise in Cabozantinib

December 28th 2011

The investigational compound cabozantinib (formerly known as XL184) has generated much excitement in recent years for its ability to target multiple pathways involved in the development of cancer.